“Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus: A Randomized Controlled Trial”

Background: Lithium remains the gold-standard treatment for bipolar disorder, with 30-40% of patients with responding preferentially to this medication 1-3. Additionally, lithium is commonly used in treatment-resistant… Read more ““Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus: A Randomized Controlled Trial””

“Brief Mindfulness Meditation for Depression and Anxiety Symptoms in Patients Undergoing Dialysis: A Randomized Control Trial”

Background: Up to 50% of hemodialysis patients suffer from symptoms of depression and/or anxiety. Access to traditional pharmacotherapies and psychotherapies for depression or anxiety in this patient… Read more ““Brief Mindfulness Meditation for Depression and Anxiety Symptoms in Patients Undergoing Dialysis: A Randomized Control Trial””